GPI and melanoma: Knockdown of glucose-6-phosphate isomerase caused glycolytic inhibition in colon cancer and melanoma cells while elevating the level of oxidative phosphorylation, which investigators consider to be a compensatory response of cells to glycolytic inhibition [42].